TrialReader


Target ADHD Executive Working Memory Study

NCT04795674 — Not applicable, Completed, 62 participants, Hartford Hospital

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Behavioral and Neural Target Engagement for ADHD Executive Working Memory Training

RegistryNCT04795674
StatusCompleted
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: single, treatment
Enrollment62 (Actual)
SponsorHartford Hospital (Other)
ConditionsADHD
InterventionsEWM Training, Placebo Training (Behavioral)
Datesstart 2021-11-01, primary completion 2023-03-19, completion 2023-03-19, first posted 2021-03-12, last updated 2023-08-02
Locations1 site in United States

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for ADHD All trials of EWM Training All trials of Placebo Training

-Summary

This study will assess whether or not a novel executive working memory training intervention for Attention-Deficit/Hyperactivity Disorder can engage frontoparietal brain network treatment targets and behavioral performance.

Expand all sections  ·  Collapse all

+Detailed description

This proposal seeks support for a 2-year milestone-driven R61 initial test of target engagement in n=62 ADHD diagnosed adolescents randomized to a 'sham training' placebo or to train 4 times each week using 4 different EWM exercises that have been combined into the format of a typical cognitive training intervention. Exercise difficulty levels in the active intervention will increase across 5 weeks to continually challenge EWM ability. EWM training will use a novel, remotely-supervised 'at home' computerized training approach. If R61 EWM training target engagement milestones are met, a 3-year R33 phase will begin. The R33 will replicate target engagement in another randomized placebo-controlled trial of n=90 new ADHD adolescents and attempt to establish a convincing link between the hypothesized targets and ADHD symptom expression. It also will characterize ADHD brain activity or EWM ability changes relative to typical levels seen in an n=40 non-ADHD control group.

+Arms and interventions

ArmTypeInterventionsDescription
ADHD EWMExperimentalBehavioral: EWM TrainingParticipants will receive EWM training sessions.
ADHD PlaceboPlacebo comparatorBehavioral: Placebo TrainingParticipants will receive placebo training sessions.
  • EWM Training (Behavioral): Training tasks will target Executive Working Memory areas of the brain. Task difficulty will be adaptively increased across the 5 weeks of training based on session-to-session performance.
  • Placebo Training (Behavioral): Computerized tasks with comparable engagement that do not tap executive working memory processes

+Outcome measures

Primary outcomes

  • Magnetic Resonance Imaging Functional Brain Scan using a Seimens 3T Skyra. [Change in fMRI measurements from baseline assessment versus 5 weeks at the conclusion of training]: fMRI measures of brain activation and functional connectivity - Conventional measures of 'brain activation' are estimated using GLM regression models that fit the fMRI BOLD timeseries data to a model of expected hemodynamic change as elicited by fMRI versions of the executive working memory training task trials. Functional connectivity is assessed using a form of cross-correlation analysis that quantifies how much the entire BOLD timeseries in different brain regions are similar to one another. Our a priori treatment target brain regions are the superior frontal sulcus and mid-lateral prefrontal cortex region of interest. Brain activity and functional connectivity specifically to these regions represent the primary outcome measures of the study.
  • The experimental executive working memory training tasks [Change in scores from baseline assessment versus 5 weeks at the conclusion of training]: Will examine changes in performance accuracy on the 4 executive working memory training tasks. These are experimental, non-published tasks being tested in this project for the first time.

+Eligibility

Sex: All, ages: 12 Years to 18 Years

Inclusion Criteria:

* Diagnosis of ADHD
* English speaking
* Right-handed
* >5th grade reading level
* >80 IQ level

Exclusion Criteria:

* Braces, metal or implant devices
* Brain abnormality, neurological disorder
* TBI or loss of consciousness>30 minutes
* Diagnosis of Psychosis, Bipolar Disorder, ASD, PTSD, OCD, SUD, Tourette's Disorder

+Locations (1)

FacilityCityCountryStatus
Institute of Living/Hartford HospitalHartford, ConnecticutUnited States

+Study documents

+Investigators

My Notes